FDA NDC Directory · JSON-LD · Markdown

Repaglinide

NDC 72603-812 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerNorthStar RxLLC
Marketing categoryAbbreviated NDA (generic) · App ANDA207209
Dosage form / routeTABLET · ORAL
Active ingredientsREPAGLINIDE (2 mg/1)
Marketing started20250408
Package count1

External sources

Source: openFDA. Public-domain (CC0).